Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) corresponding to Human GAP aa 250-350 (internal sequence). From near the SH3 domain.
Database link: P20936
Produced using Abcam's RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5, 675, 063 and/or 7, 429, 487.
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab40677 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.